Publications by authors named "Sally Hill"

Claim this Profile
P
Petosemtamab, a Bispecific Antibody Targeting Epidermal Growth Factor Receptor (EGFR) and Leucine-Rich G Repeat-Containing Protein-Coupled Receptor (LGR5) Designed for Broad Clinical Applications.
Ante S Lundberg, Cecile A W Geuijen, Sally Hill, Jeroen J Lammerts van Bueren, Arianna Fumagalli

Cancers (Basel)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tethering Natural Capital and Cultural Capital for a More Sustainable Post-COVID-19 World.
Craig A Talmage, Beth Allgood, Brien K Ashdown, Ava Brennan, Sally Hill

Int J Community Wellbeing· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insights into dog owner perspectives on risks, benefits, and nutritional value of raw diets compared to commercial cooked diets.
Alysia Empert-Gallegos, Sally Hill, Philippa S Yam

PeerJ· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Low dose angiostatic treatment counteracts radiotherapy-induced tumor perfusion and enhances the anti-tumor effect.
Esther A Kleibeuker, Emmanouil Fokas, Philip D Allen, Veerle Kersemans, Arjan W Griffioen, Sally A Hill

Oncotarget· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutaneous T-cell lymphoma (CTCL): Current practices in blood assessment and the utility of T-cell receptor (TCR)-Vβ chain restriction.
Juliet F Gibson, Jing Huang, Kristina J Liu, Kacie R Carlson, Francine Foss, Sally Hill

J Am Acad Dermatol· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VCAM-1 and VAP-1 recruit myeloid cells that promote pulmonary metastasis in mice.
Špela Ferjančič, Ana M Gil-Bernabé, Sally A Hill, Philip D Allen, Peter Richardson

Blood· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
G-CSF rescues tumor growth and neo-angiogenesis during liver metastasis under host angiopoietin-2 deficiency.
Jae Hong Im, Thomas Tapmeier, Lukxmi Balathasan, Annamaria Gal, Sabira Yameen, Sally Hill

Int J Cancer· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoxia imaging using PET and SPECT: the effects of anesthetic and carrier gas on [Cu]-ATSM, [Tc]-HL91 and [F]-FMISO tumor hypoxia accumulation.
Veerle Kersemans, Bart Cornelissen, Rebekka Hueting, Matthew Tredwell, Kamila Hussien, Sally A Hill

PLoS One· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recruitment of monocytes/macrophages by tissue factor-mediated coagulation is essential for metastatic cell survival and premetastatic niche establishment in mice.
Ana M Gil-Bernabé, Spela Ferjancic, Monika Tlalka, Lei Zhao, Philip D Allen, Sally A Hill

Blood· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual inhibition of the PI3K/mTOR pathway increases tumor radiosensitivity by normalizing tumor vasculature.
Emmanouil Fokas, Jae Hong Im, Sally Hill, Sabira Yameen, Michael Stratford

Cancer Res· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular effects dominate solid tumor response to treatment with combretastatin A-4-phosphate.
Sarah Jane Lunt, Simon Akerman, Sally A Hill, Matthew Fisher, Victoria J Wright

Int J Cancer· October 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pre-clinical evaluation of a 3-nitro-1,2,4-triazole analogue of [18F]FMISO as hypoxia-selective tracer for PET.
Romain Bejot, Veerle Kersemans, Catherine Kelly, Laurence Carroll, Robert C King, Sally Hill

Nucl Med Biol· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nitric oxide synthase inhibition enhances the tumor vascular-damaging effects of combretastatin a-4 3-o-phosphate at clinically relevant doses.
Gillian M Tozer, Vivien E Prise, Gemma Lewis, Shaoping Xie, Ian Wilson, Sally A Hill

Clin Cancer Res· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Small B-cell neoplasms with typical mantle cell lymphoma immunophenotypes often include chronic lymphocytic leukemias.
Albert K Ho, Sally Hill, Sergey N Preobrazhensky, Mark E Miller, Zhong Chen

Am J Clin Pathol· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD158k/KIR3DL2 is a useful marker for identifying neoplastic T-cells in Sézary syndrome by flow cytometry.
David W Bahler, Leah Hartung, Sally Hill, Glen M Bowen, Eric C Vonderheid

Cytometry B Clin Cytom· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blood vessel maturation and response to vascular-disrupting therapy in single vascular endothelial growth factor-A isoform-producing tumors.
Gillian M Tozer, Simon Akerman, Neil A Cross, Paul R Barber, Meit A Björndahl, Sally A Hill

Cancer Res· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypoxia-driven elimination of thiopurines from their nitrobenzyl prodrugs.
Peter Thomson, Matthew A Naylor, Michael R L Stratford, Gemma Lewis, Sally Hill

Bioorg Med Chem Lett· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combretastatin A-4-phosphate effectively increases tumor retention of the therapeutic antibody, 131I-A5B7, even at doses that are sub-optimal for vascular shut-down.
Katharine J Lankester, Ross J Maxwell, R Barbara Pedley, Jason L Dearling, Uzma A Qureshi, Sally A Hill

Int J Oncol· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and biological properties of bioreductively targeted nitrothienyl prodrugs of combretastatin A-4.
Peter Thomson, Matthew A Naylor, Steven A Everett, Michael R L Stratford, Gemma Lewis, Sally Hill

Mol Cancer Ther· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flow cytometric analysis of different CD14 epitopes can help identify immature monocytic populations.
David T Yang, Jay H Greenwood, Leah Hartung, Sally Hill, Sherrie L Perkins

Am J Clin Pathol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
T-cell large granular lymphocyte leukemias have multiple phenotypic abnormalities involving pan-T-cell antigens and receptors for MHC molecules.
Ryan Lundell, Leah Hartung, Sally Hill, Sherrie L Perkins, David W Bahler

Am J Clin Pathol· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intravital imaging of tumour vascular networks using multi-photon fluorescence microscopy.
Gillian M Tozer, Simon M Ameer-Beg, Jennifer Baker, Paul R Barber, Sally A Hill

Adv Drug Deliv Rev· January 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhancement of vascular targeting by inhibitors of nitric oxide synthase.
Peter D Davis, Gillian M Tozer, Matthew A Naylor, Peter Thomson, Gemma Lewis, Sally A Hill

Int J Radiat Oncol Biol Phys· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Z
ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculature.
Peter D Davis, Graeme J Dougherty, David C Blakey, Susan M Galbraith, Gillian M Tozer, Sally A Hill

Cancer Res· December 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective induction of tumor ischemia: development of vascular targeting agents for cancer therapy.
David J Chaplin, Sally A Hill

Curr Opin Investig Drugs· September 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis